Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Mar;50(3):187–192. doi: 10.1136/jcp.50.3.187

Cerebrospinal fluid analysis in clinical diagnosis.

A O Olukoga 1, J Bolodeoku 1, D Donaldson 1
PMCID: PMC499810  PMID: 9155666

Full text

PDF
187

Images in this article

187Image
on p.187
188Image
on p.188
188Image
on p.188
188Image
on p.188

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi N. Beta-2-microglobulin levels in the cerebrospinal fluid: their value as a disease marker. A review of the recent literature. Eur Neurol. 1991;31(4):181–185. doi: 10.1159/000116674. [DOI] [PubMed] [Google Scholar]
  2. BARROWS L. J., HUNTER F. T., BANKER B. Q. The nature and clinical significance of pigments in the cerebrospinal fluid. Brain. 1955;78(1):59–80. doi: 10.1093/brain/78.1.59. [DOI] [PubMed] [Google Scholar]
  3. Bach F., Bach F. W., Pedersen A. G., Larsen P. M., Dombernowsky P. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1703–1709. doi: 10.1016/0277-5379(89)90338-6. [DOI] [PubMed] [Google Scholar]
  4. Beelen N. A., Twijnstra A., van de Pol M., Menheere P. P. Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological disease. Eur J Cancer. 1993;29A(2):193–195. doi: 10.1016/0959-8049(93)90172-c. [DOI] [PubMed] [Google Scholar]
  5. BenGershôm E., Briggeman-Mol G. J., de Zegher F. Cerebrospinal fluid C-reactive protein in meningitis: diagnostic value and pathophysiology. Eur J Pediatr. 1986 Sep;145(4):246–249. doi: 10.1007/BF00439393. [DOI] [PubMed] [Google Scholar]
  6. Bernheimer H., Birkmayer W., Hornykiewicz O. Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien Klin Wochenschr. 1966 Jun 10;78(23):417–419. [PubMed] [Google Scholar]
  7. Chatterley S., Sun T., Lien Y. Diagnostic value of lactate dehydrogenase isoenzymes in cerebrospinal fluid. J Clin Lab Anal. 1991;5(3):168–174. doi: 10.1002/jcla.1860050304. [DOI] [PubMed] [Google Scholar]
  8. DAUGHADAY W. H., LOWRY O. H., ROSEBROUGH N. J., FIELDS W. S. Determination of cerebrospinal fluid protein with the Folin phenol reagent. J Lab Clin Med. 1952 Apr;39(4):663–665. [PubMed] [Google Scholar]
  9. Davies S. F., Gormus B. J., Yarchoan R., Kaplan M. E. Cryptococcal meningitis with false-positive cytology in the CSF. Use of T-cell rosetting to exclude meningeal lymphoma. JAMA. 1978 Jun 2;239(22):2369–2370. doi: 10.1001/jama.239.22.2369. [DOI] [PubMed] [Google Scholar]
  10. Dayan A. D., Stokes M. I. Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal-fluid cells. Lancet. 1973 Jan 27;1(7796):177–179. doi: 10.1016/s0140-6736(73)90006-8. [DOI] [PubMed] [Google Scholar]
  11. Delmotte P. Résultats comparatifs de l'électrophorèse en agar et de l'axamen par électrofocalisation des gammaglobulines du liquide céphalo-rachidien. Acta Neurol Belg. 1972 Jul-Aug;72(4):226–234. [PubMed] [Google Scholar]
  12. Delpech B., Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquide cephalo rachidien. Clin Chim Acta. 1972 Mar;37:15–23. doi: 10.1016/0009-8981(72)90410-x. [DOI] [PubMed] [Google Scholar]
  13. FRICK E. Immunophoretische Untersuchungen am Liquor cerebrospinalis. Klin Wochenschr. 1959 Jun 15;37(12):645–651. doi: 10.1007/BF01478401. [DOI] [PubMed] [Google Scholar]
  14. Farlow M., Ghetti B., Benson M. D., Farrow J. S., van Nostrand W. E., Wagner S. L. Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Lancet. 1992 Aug 22;340(8817):453–454. doi: 10.1016/0140-6736(92)91771-y. [DOI] [PubMed] [Google Scholar]
  15. Felgenhauer K., Schliep G., Rapic N. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci. 1976 Nov;30(1):113–128. doi: 10.1016/0022-510x(76)90259-8. [DOI] [PubMed] [Google Scholar]
  16. Goodson J. D., Strauss G. M. Diagnosis of lymphomatous leptomeningitis by cerebrospinal fluid lymphocyte cell surface markers. Am J Med. 1979 Jun;66(6):1057–1059. doi: 10.1016/0002-9343(79)90465-0. [DOI] [PubMed] [Google Scholar]
  17. Greenawald K. A., Speicher C. E., Evers W., Henry J. B. Glucose ontent in cerebrospinal fluid: a comparison with glucose levels in serum as determined by copper reduction and hexokinase methods. Am J Clin Pathol. 1973 Apr;59(4):518–520. doi: 10.1093/ajcp/59.4.518. [DOI] [PubMed] [Google Scholar]
  18. Griffin D. E., McArthur J. C., Cornblath D. R. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology. 1991 Jan;41(1):69–74. doi: 10.1212/wnl.41.1.69. [DOI] [PubMed] [Google Scholar]
  19. HAERER A. F., TOURTELLOTTE W. W., RICHARD K. A., GUSTAFSON G. M., BRYAN E. R. A STUDY OF THE BLOOD-CEREBROSPINAL FLUID-BRAIN BARRIER IN MULTIPLE SCLEROSIS. I. BLOOD-CEREBROSPINAL FLUID BARRIER TO SODIUM BROMIDE. Neurology. 1964 Apr;14:345–354. doi: 10.1212/wnl.14.4.345. [DOI] [PubMed] [Google Scholar]
  20. Hourani B. T., Hamlin E. M., Reynolds T. B. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med. 1971 Jun;127(6):1033–1036. [PubMed] [Google Scholar]
  21. Kabat E. A., Moore D. H., Landow H. AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS. J Clin Invest. 1942 Sep;21(5):571–577. doi: 10.1172/JCI101335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kam-Hansen S., Frydén A., Link H. B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis. Acta Neurol Scand. 1978 Aug;58(2):95–103. doi: 10.1111/j.1600-0404.1978.tb02866.x. [DOI] [PubMed] [Google Scholar]
  23. Keir G., Thompson E. J. Proteins as parameters in the discrimination between different blood-CSF barriers. J Neurol Sci. 1986 Oct;75(3):245–253. doi: 10.1016/0022-510x(86)90072-9. [DOI] [PubMed] [Google Scholar]
  24. Lampl Y., Paniri Y., Eshel Y., Sarova-Pinchas I. Alkaline phosphatase level in CSF in various brain tumors and pulmonary carcinomatous meningitis. J Neurooncol. 1990 Aug;9(1):35–40. doi: 10.1007/BF00167066. [DOI] [PubMed] [Google Scholar]
  25. Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis. Acta Neurol Scand. 1967;43(Suppl):1–136. [PubMed] [Google Scholar]
  26. Liuzzi G. M., Mastroianni C. M., Vullo V., Jirillo E., Delia S., Riccio P. Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J Neuroimmunol. 1992 Feb;36(2-3):251–254. doi: 10.1016/0165-5728(92)90058-s. [DOI] [PubMed] [Google Scholar]
  27. López-Cortés L. F., Cruz-Ruiz M., Gómez-Mateos J., Jiménez-Hernández D., Palomino J., Jiménez E. Measurement of levels of tumor necrosis factor-alpha and interleukin-1 beta in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin Infect Dis. 1993 Apr;16(4):534–539. doi: 10.1093/clind/16.4.534. [DOI] [PubMed] [Google Scholar]
  28. MARKS V., MARRACK D. Tumour cells in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1960 Aug;23:194–201. doi: 10.1136/jnnp.23.3.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. MARKS V. True glucose content of lumbar and ventricular cerebrospinal fluid. J Clin Pathol. 1960 Jan;13:82–84. doi: 10.1136/jcp.13.1.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Maimone D., Gregory S., Arnason B. G., Reder A. T. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol. 1991 Apr;32(1):67–74. doi: 10.1016/0165-5728(91)90073-g. [DOI] [PubMed] [Google Scholar]
  31. McArthur J. C., Nance-Sproson T. E., Griffin D. E., Hoover D., Selnes O. A., Miller E. N., Margolick J. B., Cohen B. A., Farzadegan H., Saah A. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology. 1992 Sep;42(9):1707–1712. doi: 10.1212/wnl.42.9.1707. [DOI] [PubMed] [Google Scholar]
  32. Porter K. G., Sinnamon D. G., Gillies R. R. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis. Lancet. 1977 Jun 11;1(8024):1262–1262. doi: 10.1016/s0140-6736(77)92473-4. [DOI] [PubMed] [Google Scholar]
  33. Schliep G., Felgenhauer K. The alpha2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier. J Neurol. 1974;207(3):171–181. doi: 10.1007/BF00312558. [DOI] [PubMed] [Google Scholar]
  34. Thompson E. J., Keir G. Laboratory investigation of cerebrospinal fluid proteins. Ann Clin Biochem. 1990 Sep;27(Pt 5):425–435. doi: 10.1177/000456329002700503. [DOI] [PubMed] [Google Scholar]
  35. Torack R. M. Historical aspects of normal and abnormal brain fluids. I. Cerebrospinal fluid. Arch Neurol. 1982 Apr;39(4):197–201. doi: 10.1001/archneur.1982.00510160003001. [DOI] [PubMed] [Google Scholar]
  36. Torack R. M. Historical aspects of normal and abnormal brain fluids. I. Cerebrospinal fluid. Arch Neurol. 1982 Apr;39(4):197–201. doi: 10.1001/archneur.1982.00510160003001. [DOI] [PubMed] [Google Scholar]
  37. WROBLEWSKI F., DECKER B., WROBLEWSKI R. Activity of lactic dehydrogenase in spinal fluid. Am J Clin Pathol. 1957 Sep;28(3):269–271. doi: 10.1093/ajcp/28.3.269. [DOI] [PubMed] [Google Scholar]
  38. Watson M. A., Scott M. G. Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem. 1995 Mar;41(3):343–360. [PubMed] [Google Scholar]
  39. Whitaker J. N., Lisak R. P., Bashir R. M., Fitch O. H., Seyer J. M., Krance R., Lawrence J. A., Ch'ien L. T., O'Sullivan P. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol. 1980 Jan;7(1):58–64. doi: 10.1002/ana.410070111. [DOI] [PubMed] [Google Scholar]
  40. van Gool W. A., Bolhuis P. A. Cerebrospinal fluid markers of Alzheimer's disease. J Am Geriatr Soc. 1991 Oct;39(10):1025–1039. doi: 10.1111/j.1532-5415.1991.tb04052.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES